Diabetes impairs sciatic nerve hyperemia induced by surgical trauma: implications for diabetic neuropathy.
The most widely used methods to assess nerve blood flow in diabetics rats are hydrogen clearance polarography and laser Doppler flowmetry, techniques requiring surgical exposure of the nerve. In these experiments, we examined the hypothesis that the trauma of surgical exposure introduces an important and hitherto largely unrecognized variable that could account for discordant reports on nerve blood flow changes induced by diabetes. We used the noninvasive (for sciatic nerve) reference sample microsphere method to quantify sciatic nerve blood flow in unexposed va. surgically exposed nerves in rats with streptozotocin-induced diabetes (at different temperatures and after curarization) and in unexposed vs. surgically exposed nerves in galactose-fed rats. Baseline resting blood flow in unexposed nerves in both animal models of diabetes was either normal or increased (but was decreased in diabetic rats given d-tubocurarine). Furthermore, the normal brisk hyperemic nerve blood flow response to the minimal trauma associated with surgical exposure of the nerve was markedly impaired in diabetic and in galactose-fed rats. Normalization of the blood flow response to trauma in galactose-fed rats by an aldose reductase inhibitor suggests that the impairment is linked to increased polyol pathway metabolism. These findings 1) confirm our previous findings that sciatic nerve blood flow in diabetic rats is increased or unchanged in unexposed nerves, while also confirming reports that in surgically exposed nerves blood flow is higher in control than in diabetic rats, and 2) indicate that blood flows in surgically exposed nerves are largely a measure of vascular responses to injury rather than (patho)physiological blood flow in undisturbed nerves.
Ido
Y
Y
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Chang
K
K
LeJeune
W
W
Tilton
R G
RG
Monafo
W W
WW
Williamson
J R
JR
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D003891:Desipramine; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D003929:Diabetic Neuropathies / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005682:Gadolinium; D005690:Galactose / Q000494:pharmacology; D006439:Hemodynamics; D006940:Hyperemia / Q000503:physiopathology*; D007249:Inflammation; D017078:Laser-Doppler Flowmetry; D008297:Male; D008863:Microspheres; D009281:Naphthalenes / Q000494:pharmacology; D009493:Neurosurgery; D011048:Polarography; D011868:Radioisotopes; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow; D012584:Sciatic Nerve / Q000098:blood supply* / Q000503:physiopathology / Q000601:surgery; D013997:Time Factors; D014316:Tritium; D014947:Wounds and Injuries
D004791:Enzyme Inhibitors; D009281:Naphthalenes; D011868:Radioisotopes; C040550:tolrestat; D014316:Tritium; D005682:Gadolinium; D000449:Aldehyde Reductase; D003891:Desipramine; D005690:Galactose